Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;69(11):931-942.
doi: 10.1007/s00106-021-01110-4. Epub 2021 Oct 13.

[Epistaxis-overview and current aspects]

[Article in German]
Kruthika Thangavelu  1 , Sabine Köhnlein  2 , Behfar Eivazi  2   3 , Mariana Gurschi  4 , Boris A Stuck  2 , Urban Geisthoff  2
Affiliations

[Epistaxis-overview and current aspects]

[Article in German]
Kruthika Thangavelu et al. HNO. 2021 Nov.

Abstract
in English, German

Nosebleeds (epistaxis) are usually minor. Medical intervention is only necessary in about 6% of cases. The source of bleeding is frequently located in the anterior region of the nose (Kiesselbach's plexus). The estimated lifetime prevalence of epistaxis is 60%. Diffuse epistaxis is often a manifestation of systemic disease. Epistaxis is the leading symptom of Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia, HHT). If intervention is required, the first-choice of treatment is bidigital compression for several minutes. Common therapeutic measures include local hemostasis using electrocoagulation or chemical agents, e.g., silver nitrate. Resorbable anterior nasal tampons or tampons with a smooth surface are also frequently employed. In case of failed surgical closure of the sphenopalatine artery, angiographic embolization is the method of choice.

Meist handelt es sich beim Nasenbluten (Epistaxis) um kleinere Blutungen. Medizinische Maßnahmen sind nur in etwa 6 % der Fälle erforderlich. Oft liegt die Blutungsquelle im vorderen Nasenabschnitt (Locus Kiesselbachii). Die geschätzte Gesamtlebenszeitprävalenz für Epistaxis beträgt 60 %. Tritt die Epistaxis in diffuser Form auf, so ist das häufig die Manifestation einer systemischen Erkrankung. Beim M. Rendu-Osler-Weber (hereditäre hämorrhagische Teleangiektasie, HHT) stellt die Epistaxis das Leitsymptom dar. Erstmaßnahme der Wahl bei Interventionsbedarf ist die bidigitale Kompression über mehrere Minuten. Verbreitete Therapiemaßnahmen sind u. a. die lokale Blutstillung mittels Elektrokoagulation oder mit chemischen Mitteln wie Silbernitrat. Auch resorbierbare vordere Nasentamponaden oder Tamponaden mit glatter Oberfläche werden häufig eingesetzt. Beim Versagen des chirurgischen Gefäßverschlusses der A. sphenopalatina ist die angiographische Embolisation Methode der Wahl.

Keywords: Hemorrhage; Hereditary hemorrhagic telangiectasia; Nasal bleeding; Nose diseases; Vascular diseases.

PubMed Disclaimer

References

Literatur

    1. Tunkel DE, Anne S, Payne SC et al (2020) Clinical practice guideline: nosebleed (Epistaxis) executive summary. Otolaryngol Head Neck Surg 162:8–25 - PubMed
    1. Viehweg TL, Roberson JB, Hudson JW (2006) Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 64:511–518 - PubMed
    1. Benninger MS, Marple BF (2004) Minor recurrent epistaxis: prevalence and a new method for management. Otolaryngol Head Neck Surg 131:317–320 - PubMed
    1. Cooper SE, Ramakrishnan VR (2012) Direct cauterization of the nasal septal artery for epistaxis. Laryngoscope 122:738–740 - PubMed
    1. Lin G, Bleier B (2016) Surgical management of severe epistaxis. Otolaryngol Clin North Am 49:627–637 - PubMed

LinkOut - more resources